EIT Pharma Grabs $35M Series A
2026-09-03
Tweet
KIRKLAND, WA, EIT Pharma, a biotechnology company focused on developing therapies for infectious diseases, announced a $35 million Series A.
EIT Pharma, a biotechnology company focused on developing therapies for infectious diseases, announced a $35 million Series A led by Propel Bio Partners, with participation from Good Ventures and Arrowtown.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors
